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 ABSTRACT 
 Increased levels of estrogen metabolites are believed 
to be associated with cancers of the reproductive sys-
tem. One potential dietary source of these metabolites 
that is commonly consumed worldwide is milk. In North 
America, dairy cows are the most common source of 
milk; however, goats are the primary source of milk 
worldwide. In this study, the absolute concentrations of 
unconjugated and total (unconjugated plus conjugated) 
estrone (E1) and 17β-estradiol (E2) were compared in a 
variety of commercial cow milks (regular and organic) 
and goat milk. A lower combined concentration of E1
and E2 was found in goat milk than in any of the cow 
milk products tested. The differences in E1 and E2 lev-
els between regular and organic cow milks were not as 
significant as the differences between goat milk and any 
of the cow milk products. Goat milk represents a better 
dietary choice for individuals concerned with limiting 
their estrogen intake. 
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INTRODUCTION
 Although cow milk is the most consumed milk in 
North America, several studies indicate that goat milk 
is the most ingested milk globally (Haenlein, 2001). 
The nutritional and medical benefits of goat milk have 
been widely acknowledged, but little unbiased medical 
research has been conducted and the physiological and 
biochemical properties of goat milk are barely known 
(Haenlein, 2004). Given the expressed need for further 
research regarding milk consumption and increased 
cancer risk, it is imperative to further explore milk 
products that are consumed on a regular basis, particu-
larly goat milk, given its worldwide prevalence (Willett, 
2003; Larsson et al., 2004; Courant et al., 2008). More-
over, the need to directly compare goat and cow milk to 
better understand the benefits and limitations of each 
has been expressed by the Dairy Research and Informa-
tion Center (http://drinc.ucdavis.edu/goat1.htm). 
 The popularity of using goats as a dairy source has 
risen in recent years because they require minimal 
land use. In addition, goats are often maintained on 
pasture that would otherwise be inaccessible to other 
dairy animals with no decrease in the nutritive value 
of their milk (Larsson et al., 2004). Even though there 
are obvious benefits to their use as dairy animals, the 
goat milk industry has not flourished in the United 
States, a truth made evident by the fact that goat milk 
is largely sold in specialty stores or purchased directly 
from the farmer. Part of the reason lies in the fact that 
most small dairymen have great difficulty with meeting 
government sanitation standards for commercial prod-
ucts. In spite of these difficulties, the top producers of 
commercially available goat milk in the United States 
have increased production more than 30% to keep up 
with demand. This increased demand is likely due to 
the growing ethnic diversity in the United States today; 
consequently, it is expected that the goat industry will 
continue to expand as long as the ethnic population 
continues to grow. 
 The literature suggests that goat milk has higher 
nutritional value than cow milk. Goat milk has higher 
concentrations of phosphorous, potassium, vitamin A, 
and calcium; cow milk does, however, have a higher 
concentration of folate (Willett et al., 2003; Qin et al., 
2004; Courant et al., 2008). Although conventional 
thought suggests that cow milk is the best source of 
calcium, goat milk actually provides more calcium per 
serving (Willett, 2003; Courant et al., 2008). Cow milk 
supplies approximately 276 mg of calcium per cup com-
pared with 327 mg per cup for goat milk (Qin et al., 
2004). Although this 19% increase in calcium content 
may be small, it may be an important factor for grow-
ing children and individuals suffering from osteoporosis. 
 Allergic reactions to cow milk proteins have become 
increasingly common (Dias et al., 2010). Many allergies 
are related to the protein casein αS1, which is a found 
in higher concentration in cow milk than in goat milk 
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(Savilahti et al., 2010). Lactalbumin, which can also 
provoke allergic reactions, specifically in small children, 
is not present in goat milk (Solinas et al., 2010). The 
presence of simpler, smaller proteins and fat molecules 
is considered to be one of the primary reasons why goat 
milk is easier to digest than cow milk (Coila, 2010). 
Another possible reason for easier digestion may be 
that the fat globules in goat milk do not cluster due 
to the lack of the protein agglutinin, which is found in 
cow milk (http://fiascofarm.com/dairy/rawmilk.htm).
The largest health concern for consumers of goat 
milk is likely to be its elevated fat content compared 
with cow milk. Whereas goat milk has 10.1 g of fat per 
a single cup serving, cow milk contains 7.9 g (Liehr, 
2000; Ganmaa and Sato, 2005). More troubling for con-
sumers, perhaps, is how much of the fat content in goat 
milk is composed of saturated fat. Goat milk has 6.5 
g of saturated fat per cup compared with 5.0 g in cow 
milk. Despite its higher content, the fat in goat milk is 
easier to digest than that found in cow milk due to the 
fact that more of the fat is made of short- and medium-
chain fatty acids. However, because low-fat and non-fat 
varieties of goat milk are hard to find commercially, if 
one is looking to have a heart-healthy diet that includes 
dairy, the literature suggests goat milk may not be the 
best alternative to cow milk.
Due to the lower lactose quantities of goat milk (4.1%) 
compared with cow milk (4.7%), research indicates that 
goat milk may be more easily digested and tolerated by 
individuals who are slightly or mildly lactose intolerant. 
Even the slightly lower lactose levels, however, are not 
enough to make goat milk consumable by individuals 
who are fully lactose intolerant (Bernstein and Ross, 
1993).
One group of functional molecules that have not been 
widely compared within the dairy industry is steroid 
hormones, in particular estrogens. According to numer-
ous epidemiological studies in recent decades, estrogens 
are now considered to be risk factors for cancer, par-
ticularly in the breasts, ovaries, and prostate (Chen et 
al., 2006; Yager and Davidson, 2006). Given that milk 
and dairy intake account for 60 to 70% of total estro-
gen consumption, it is important to investigate com-
mercially available milk products to better understand 
whether they pose a risk factor for cancer (Ganmaa and 
Sato, 2005; Farlow et al., 2009).
MATERIALS AND METHODS
Reagents and Materials
Estrone (E1) and 17β-estradiol (E2) standards were 
obtained from Steraloids Inc. (Newport, RI). The stable 
isotope-labeled estrogens, estradiol-13,14,15,16,17,18-
13C6 (
13C6-E2) and estrone-13,14,15,16,17,18-
13C6 
(13C6-E1), were purchased from Cambridge Isotope 
Laboratories Inc. (Andover, MA). Both E1 and E2 were 
used without further purification and have reported 
chemical and isotopic purities ≥98%. Dichloromethane, 
methanol, and formic acid were obtained from EM 
Science (Gibbstown, NJ). Glacial acetic acid, sodium 
bicarbonate, and l-ascorbic acid were purchased from 
J. T. Baker Inc. (Phillipsburg, NJ). Sodium hydroxide 
and sodium acetate were purchased from Fisher Scien-
tific Co. LLC (Fair Lawn, NJ). β-Glucuronidase/sul-
fatase (Helix pomatia, Type HP-2) was obtained from 
Sigma Chemical Co. (St. Louis, MO). Dansyl chloride 
and acetone were purchased from Aldrich Chemical Co. 
(Milwaukee, WI). All chemicals and solvents used in 
this study were HPLC or reagent grade.
Milk Samples
Seven milk samples were collected for this study: 
whole milk, 2% milk, nonfat milk, organic whole milk, 
organic 2% milk, organic nonfat milk, and regular goat 
milk. All milk samples are assumed to be from cows un-
less otherwise indicated. The cow milks were produced 
by Bloom (Salisbury, NC) and purchased at a local 
grocery store (Bloom, Frederick, MD). The goat milks 
were purchased at MOM’s Organic Market (Frederick, 
MD). Milk was aliquoted and stored at −40°C until 
analyzed. Each sample was analyzed in triplicate in 
4 separate batches, yielding a total of 12 analyses for 
each milk product.
Preparation of Stock and Working  
Standard Solutions
Stock solutions of E1 and E2 were prepared at a 
concentration of 80 μg/mL by dissolving 2 mg of each 
steroid hormone in 25 mL of methanol containing 0.1% 
(wt/vol) l-ascorbic acid. Time-dependent degrada-
tion of the standards within the stock solutions was 
monitored by measuring the absolute peak height of E1 
and E2 using capillary liquid chromatography-tandem 
mass spectrometry (LC-MS/MS). No degradation 
was observed for these solutions stored at least 2 mo 
at −20°C. Working standard solutions of E1 and E2 
(as well as the stable isotope-labeled versions of these 
steroid hormones) having a concentration of 8 ng/mL 
were prepared by diluting the stock solutions with 
methanol containing 0.1% (wt/vol) l-ascorbic acid.
Calibration Standards
Milk fortified with 0.1% (wt/vol) l-ascorbic acid 
and having no detectable levels of estrogen metabolites 
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was used for preparation of calibration standards and 
quality control samples. Calibration standards were 
prepared by adding 20 μL of the stable isotope working 
internal standard (SI) solution (0.16 ng of SI-E1 or E2) 
to various volumes of working standard solution, which 
typically contained 0.002 to 2 ng of each metabolite. 
Each calibration standard was assayed in duplicate. 
Quality control samples were prepared containing 8, 
40, and 160 pg/mL (26.5–29.6, 132.4–148.0, and 529.5–
592.2 fmol/mL) of E1 and E2. The accuracy (measured 
as the percent matching of calculated amount to known 
amount of E1 and E2 in control samples) and precision 
(measured as the percent relative standard deviations) 
of the quality control samples are provided in Table 1. 
Calibration curves generated for E1 and E2 are provided 
in Figure 1. These calibration curves were linear over 
a 103-fold range (0.2 to 200 pg on column) with coef-
ficient of determination greater than 0.998.
Sample Preparation
The methods used to prepare the samples (Xu et 
al., 2005, 2007a; Farlow et al., 2009) were designed to 
specifically target the following: 1) biologically active, 
unconjugated parent E1 and E2 and 2) total (biologi-
cally active plus their sulfate or glucuronide conjugates, 
or both) levels of E1 and E2. For measuring total milk 
E1 and E2 levels (EM), 20 μL of the stable isotope 
containing working internal standard solution (0.16 ng 
of SI-EM) was added to a 2-mL aliquot of milk, fol-
lowed by addition of 7 mL of methanol. After 30 min 
of inverse extraction, the sample was centrifuged at 
2,500 × g for 30 min. The supernatant was transferred 
to a clean screw-capped glass tube, and the methanol 
evaporated by heating at 60°C (Reacti-Vap III; Pierce 
Biotechnology Inc., Rockford, IL) under a stream of 
N2 gas. Freshly prepared enzymatic hydrolysis buffer 
(0.5 mL) containing 5 mg of l-ascorbic acid, 15 μL of 
β-glucuronidase/sulfatase, and 1.5 mL of 0.15 M so-
dium acetate buffer (pH 4.6) was prepared as described 
previously. After sulfatase and glucuronidase hydrolysis 
by incubation for 20 h at 37°C, 8 mL of dichlorometh-
ane was added and the samples underwent slow inverse 
extraction at 8 rpm (RKVSD; ATR Inc., Laurel, MD) 
for 30 min. After extraction, the organic solvent portion 
was transferred into a clean glass tube and evaporated 
Table 1. Accuracy and precision (%)1 of measurements of quality control samples for estrogen measurements 
Item
Accuracy Precision
80 pg/mL 40 pg/mL 160 pg/mL 80 pg/mL 40 pg/mL 160 pg/mL
E1 101.5 101.9 100.5 7.09 5.95 4.30
E2 97.2 99.8 98.9 6.39 3.30 2.94
1Accuracy was measured as the percent matching of the calculated amount to known amount of milk estrone 
(E1) and 17β-estradiol (E2) in control samples. Precision was measured as the percent relative standard devia-
tion.
Figure 1. Calibration curves for A) estrone and B) 17β-estradiol 
measured in the various milk products tested.
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to dryness at 60°C under N2 gas (Reacti-Vap III; Pierce 
Biotechnology Inc.). To the dried sample, 100 μL of 0.1 
M sodium bicarbonate buffer (pH at 9.0) and 100 μL 
of dansyl chloride solution (1 mg/mL in acetone) were 
added. The sample was vortexed and heated at 60°C 
(Reacti-Therm III Heating Module; Pierce Biotechnol-
ogy Inc.) for 5 min to produce the E1 and E2 and stable 
isotope-labeled E1 and E2 dansyl derivatives (E1-dansyl, 
E2-dansyl, SI-E1-dansyl, and SI-E2-dansyl, respective-
ly). Calibration standards were hydrolyzed, extracted, 
and derivatized following the same procedure. After 
derivatization, all samples were analyzed by LC-MS/
MS. For the measurement of total (unconjugated plus 
conjugated) E1 and E2 levels, identical sample prepara-
tion was used with the omission of the β-glucuronidase/
sulfatase hydrolysis step.
Capillary LC-MS/MS Analysis
Quantitative analysis was performed using an Agilent 
1200 Series Nanoflow LC system (Agilent Technologies 
Inc., Palo Alto, CA) coupled to a TSQ Quantum Ultra 
triple quadrupole mass spectrometer (Thermo Electron 
Corp., San Jose, CA). The LC separation was conduct-
ed using a 150-mm long × 300-μm i.d. column packed 
with 4 μm of Synergi Hydro-RP particles (Phenomenex 
Inc., Torrance, CA), maintained at 40°C. A total of 8 
μL of each sample was injected onto the column. The 
mobile phases consisted of methanol as solvent A and 
0.1% (vol/vol) formic acid in water as solvent B. A 
linear gradient from 72 to 85% solvent B in 75 min, at a 
flow rate of 4 μL/min, was used for separation of E1 and 
E2. The MS conditions were as follows: source: ESI; ion 
polarity: positive; spray voltage: 3,500 V; sheath and 
auxiliary gas: nitrogen; sheath gas pressure: 7 arbitrary 
units; ion transfer capillary temperature: 270°C; scan 
type: selected reaction monitoring; collision gas: argon; 
collision gas pressure: 0.2 Pa; scan width: 0.7 unit 
resolution (u); scan time: 0.50 s; Q1 peak width: 0.70 
u full-width half-maximum (FWHM); Q3 peak width: 
0.70 u FWHM. The optimized selected reaction moni-
toring conditions for the protonated molecules [M+H+] 
of EM-dansyl and SI-EM-dansyl were similar to those 
described previously [23,24; thus, a charge state of 1]. 
Briefly, E1 m/z 504→171 collision energy: 32 eV; E2 
m/z 506→171 collision energy: 35 eV.
?????????????????????????????????????????
Quantitation of E1and E2 was carried out using 
Xcalibur Quan Browser (Thermo Finnigan Corp., San 
Jose, CA). Calibration curves for each metabolite were 
constructed by plotting E1-dansyl/SI-E1-dansyl and 
E2-dansyl/SI-E2-dansyl peak area ratios obtained from 
calibration standards versus amounts of each steroid 
hormone and fitting these data using linear regression 
with 1/X weighting. The amount of E1 and E2 in milk 
samples was interpolated using this linear function. 
Based on their similarity of structures and retention 
times, 13C6-E1 and 
13C6-E2 were used as the internal 
standards for E1 and E2.
RESULTS
In this study, the levels of unconjugated and total 
(unconjugated + conjugated) E1 and E2 were measured 
in a variety of commercially available cow and goat 
milk products. Unconjugated refers to the free, biologi-
cally active forms of these steroid hormones, whereas 
total includes both the unconjugated and conjugated 
levels. To measure the total levels, the conjugated forms 
of E1 and E2 (i.e., sulfated and glucuronidated) are 
converted to the unconjugated forms by treating the 
samples with a sulfatase/glucuronidase enzyme before 
LC-MS/MS analysis. Representative chromatograms 
showing the detection of unconjugated E1 and E2 in 
the milk products analyzed in this study are shown in 
Figures 2A and B, respectively. Although comparisons 
between the levels of these steroid hormones cannot be 
made directly from these figures, they do illustrate the 
excellent signal-to-noise ratio that was observed in the 
measurements. Representative chromatograms showing 
the detection of total (unconjugated + conjugated) E1 
and E2 in the milk products analyzed in this study are 
shown in Figure 3A and B, respectively. The signal-
to-noise ratio of these chromatograms was significantly 
higher than that of their respective counterparts in Fig-
ure 2, indicating that E1 and E2 exist in milk primarily 
in their conjugated forms.
The absolute concentrations of unconjugated E1 and 
E2 detected in this study for all commercially avail-
able milk forms are shown in Figure 4A and listed in 
Table 2 (mean ± standard deviation of 12 samples). 
Regular whole (14.45 pg/mL) and regular 2% (13.58 
pg/mL) cow milks contain the highest concentrations 
of unconjugated E1. Goat milk contains the lowest 
concentration of biologically active E1 (1.45 pg/mL). 
The concentration of E1 in goat milk was more than 
3-fold less than that found in any of the other milk 
products tested. The highest concentrations of biologi-
cally active E2 were found in organic (6.00 pg/mL) and 
regular whole (5.84 pg/mL) cow milks. Whereas goat 
milk contained 1.82 pg/mL, the lowest unconjugated E2 
levels were found in organic nonfat (0.48 pg/mL) and 
regular nonfat (0.63 pg/mL) milks.
The sum of the unconjugated concentrations of E1 
and E2 were significantly lower in goat milk (3.27 pg/
mL) than any of the other milks tested (Table 2). This 
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concentration was only 16% of that found in regular 
whole milk, which contained the highest accumulative 
concentration of E1 and E2. The sum of the unconju-
gated concentration of E1 and E2 was 1.75- and 1.49-
fold higher in regular nonfat and organic nonfat milk 
compared with goat milk, respectively. These results 
show that goat milk contains a substantially lower con-
centration of unconjugated E1 and E2 levels compared 
with any of the varieties of cow milks that were tested.
The total (unconjugated + conjugated) concentra-
tions of both steroid hormones in each milk product 
are shown in Table 3 and Figure 4B. As with the un-
conjugated levels, the absolute concentrations of total 
E1 and E2 detected in this study for all commercially 
available milk forms are provided as data expressed as 
mean ± standard deviation of 12 samples. Overall, the 
data indicate that E1 and E2 exist in milk primarily in 
their various conjugated forms (i.e., glucuronidated and 
Figure 2. High performance liquid chromatography-tandem mass spectrometry selected reaction monitoring (SRM) chromatographic profiles 
of A) unconjugated estrone (E1) and B) 17β-estradiol (E2) in all milk forms analyzed in this study.
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sulfated, among others). This result is not surprising, 
as both E1 and E2 have been previously shown to ex-
ist primarily in conjugated forms in human serum (Xu 
et al., 2007b). Whereas regular whole and regular 2% 
milks contained the highest concentrations of uncon-
jugated E1, organic whole (260.0 pg/mL) and organic 
2% (240.5 pg/mL) contained the highest concentration 
of total E1. In fact, all of the organic milks contained 
higher concentrations of total E1 than any of the regu-
lar milks. Goat milk (42.8 pg/mL) contained only 33% 
of the total E1 compared with any of the other 6 milk 
products. Similar to the trend observed for E1, the 
highest concentrations of total E2 were found in organic 
whole (61.5 pg/mL), organic 2% (52.8 pg/mL), and 
organic nonfat (38.0 pg/mL) milks. All of these concen-
trations were higher than those observed in any of the 
regular milks (28.2–31.3 pg/mL). Goat milk contained 
the lowest concentration of both total E1 (42.8 pg/mL) 
Figure 3. High performance liquid chromatography-tandem mass spectrometry selected reaction monitoring (SRM) chromatographic profiles 
of A) total (unconjugated + conjugated) estrone (E1) and B) 17β-estradiol (E2) in all milk forms analyzed in this study.
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and E2 (17.9 pg/mL). The sum of the concentrations 
of total E1 and E2 in goat milk was only 38% of that in 
any of the cow milk products tested. In fact, the sum of 
the concentrations of total E1 and E2 in goat milk was 
less than 20% of that observed for organic whole milk, 
which contained the highest combined levels of total E1 
and E2.
Organic nonfat (2.5%) and goat (3.4%) milk con-
tained the lowest percentage of unconjugated compared 
with total E1 concentrations, whereas regular whole 
Figure 4. Bar chart showing the absolute levels of A) free (unconjugated) and B) total (unconjugated + conjugated) estrone (E1) and 
17β-estradiol (E2) measured in the milk products analyzed in this study. Color version available in the online PDF.
Table 2. Unconjugated (i.e., free) estrogen concentrations (pg/mL) of estrone (E1) and 17β-estradiol (E2) found in milk (data are expressed as 
means ± SD of 12 samples for each form of milk) 
Item
Regular  
whole
Regular  
2%
Regular  
nonfat
Organic  
whole
Organic  
2%
Organic  
nonfat
Regular  
goat
E1 14.45 ± 1.49 13.58 ± 1.00 5.08 ± 0.20 9.74 ± 0.39 11.95 ± 0.42 4.39 ± 0.23 1.45 ± 0.07
E2 5.84 ± 0.63 2.65 ± 0.33 0.63 ± 0.10 6.00 ± 0.46 2.24 ± 0.19 0.48 ± 0.02 1.82 ± 0.04
Total 20.29 ± 2.12 16.23 ± 1.33 5.71 ± 0.30 15.74 ± 0.85 14.19 ± 0.61 4.87 ± 0.25 3.27 ± 0.11
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(11.1%) and regular 2% (9.8%) milk contained the 
highest percentage. Organic nonfat (1.3%) and regular 
nonfat (2.0%) milk contained the lowest percentage 
of unconjugated compared with total E2 concentra-
tions, whereas regular whole (20.7%) and regular goat 
(10.2%) milk contained the highest percentage. The 
difference between unconjugated and total forms was 
smallest for regular whole milk and largest for organic 
nonfat milk, where the data suggest that over 87% of 
E1 and E2 in regular whole milk is conjugated, whereas 
this percentage is over 97% for organic nonfat milk. On 
average, the data shows that only about 6% of E1 and 
E2 are found in the unconjugated, biologically active 
forms in the milk products tested.
The rather dramatic decrease in levels of unconju-
gated E1 and E2 compared with total values from whole 
and 2% to nonfat in both regular and organic milks is 
likely due to the higher aqueous composition of nonfat 
milks combined with the higher fat solubility of these 
compounds. In total form, however, all regular cow 
milks display relatively consistent levels of total E1 plus 
E2 (ranging from 158.06 to 168.25 pg/mL), whereas 
organic milks were much more inconsistent (ranging 
from 213.40 to 321.54 pg/mL). The total forms of E1 
and E2 for goat milk were dramatically lower compared 
with regular and organic milk, with a concentration of 
60.65 pg/mL. Total and unconjugated forms of E1 and 
E2 for all milks forms ranged from 60.65 to 321.54 pg/
mL and 3.27 to 20.29 pg/mL, respectively.
DISCUSSION
In this study, the concentrations of E1 and E2 were 
compared between goat milk and 6 commonly consumed 
cow milk products. The accumulative concentrations of 
unconjugated and total E1 and E2 were significantly 
lower in goat milk compared with the cow milks tested. 
In particular, the total levels of E1 and E2 were no more 
than 38% of that contained in any of the cow milks 
tested. When comparing these steroid hormone levels 
in goat and cow milk, the obvious question that comes 
to mind for concerned consumers is which product is 
safer for consumption. For those concerned with E1 
and E2 consumption, the data from this study indicates 
that goat milk is safer to consume than all forms of 
regular cow milk. Goat milk is consistently lower in 
both conjugated and unconjugated estrogens. Another 
possible point of concern for consumers is the presence 
of catechol estrogens in milk products. Significant data 
have been produced to show that catechol estrogens are 
strong promoters for carcinogenesis, but currently very 
little literature exists regarding the quantitation of the 
following catechol estrogens in commercial milk prod-
ucts: 2-hydroxyestrone (2-OHE1), 2-hydroxyestradiol 
(2-OHE2), and 4-hydroxyestrone (4-OHE1; Yager and 
Davidson, 2006; Farlow et al., 2009). These catechol 
estrogens are of particular concern because of their 
highly reactive nature. Although catechol estrogens 
were not quantitated in this study, based on estrogen 
metabolisms, their levels would also be lower in goat 
milk compared with regular milk. This study particu-
larly stressed the importance of quantitating E1 and E2 
in goat milk because of the following: 1) no study has 
attempted (to the best of our knowledge) to quantitate 
E1 and E2 in the most commonly consumed milk in the 
world (goat milk) and 2) E1 and E2 are the most com-
mon estrogen metabolites and are the precursors from 
which other estrogen metabolites are derived, including 
2-OHE1, 2-OHE2, and 4-OHE1.
Although the main focus of this article was to pro-
vide an objective comparison describing the E1 and E2 
concentrations in goat and regular cow milk, it is also 
useful to examine their content in organic cow milks 
due to their increasing popularity as healthy food al-
ternatives. As seen in Tables 2 and 3, all organic milks 
were lower in the biologically active, unconjugated E1 
and E2 and higher in total concentrations of each when 
compared directly to their regular milk counterparts. 
This fact is significant according to a previous study 
that suggested that the half-lives of conjugated estro-
gens are longer than those of nonconjugated estrogens 
due to first mass metabolism in the liver (Schindler et 
al., 1982). Also significant is the fact that goat milk 
is lower in unconjugated and total E1 and E2 than all 
other forms of regular and organic milks. These results 
show that goat milk has less biologically active EM and 
shorter half-lives for its conjugated estrogens than all 
other milk forms tested in this study.
Comparing the conjugated E1 and E2 concentrations 
found in the milk products analyzed in this study to 
Table 3. Unconjugated + conjugated (i.e., total) concentrations (pg/mL) of estrone (E1) and 17β-estradiol (E2) found in milk (data are 
expressed as means ± SD of 12 samples for each form of milk) 
Item
Regular  
whole
Regular  
2%
Regular  
nonfat
Organic  
whole
Organic  
2%
Organic  
nonfat
Regular  
goat
E1 129.9 ± 18.48 138.7 ± 22.28 129.2 ± 17.72 260.0 ± 28.32 240.5 ± 22.16 175.4 ± 34.53 42.78 ± 4.28
E2 28.19 ± 5.26 29.57 ± 5.31 31.28 ± 3.85 61.52 ± 11.84 52.82 ± 6.06 38.02 ± 6.89 17.87 ± 2.80
Total 158.1 ± 23.74 168.3 ± 27.59 160.5 ± 21.57 321.5 ± 40.16 293.3 ± 28.22 213.4 ± 41.42 60.65 ± 7.08
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those administered during hormone therapy is useful 
for individuals concerned about estrogen intake via di-
etary consumption. A previous study showed that con-
jugated estrogen metabolite concentrations in several 
commercial milk products, mostly regular milk, were 
low compared with the conjugated equine estrogens in 
low-dose (300 μg) and regular-dose (625 μg) Premarin 
(Farlow et al., 2009). Premarin is a hormone replace-
ment therapy that is associated with breast cancer 
incidence in post-menopausal women after long-term 
exposure (Beral, 2003; Chen et al., 2006). The level of 
conjugated estrogen metabolites in 1 L of skim milk 
was approximately 0.15% of the amount of conjugated 
E1 and E2 administered through low-dose Premarin and 
only 0.07% of that obtained through a regular dose.
Similarly, in this study, conjugated E1 and E2 con-
centrations were quite low for all milk types, particu-
larly goat milk. The ratios of conjugated E1 and E2 
compared with those found in low and regular doses 
of Premarin are provided in Table 4 for all types of 
milk products analyzed in this study. Conjugated ste-
roid hormone values were determined by subtracting 
the unconjugated values from the total values pre-
sented for E1 and E2 in Tables 2 and 3, respectively. 
The data presented in Table 4 clearly indicates that 
all milk forms are significantly lower in conjugated EM 
concentration than those administered by Premarin for 
hormone replacement therapy. Although this indica-
tion may seem rather obvious, it nevertheless provides 
consumers with useful baseline values with which to 
compare milk products. The great difference regard-
ing conjugated E1 and E2 concentrations between low-, 
regular-dose Premarin and commercially available milk 
products should provide consumers concerned about 
EM in milk products with relative comfort; however, 
no definitive conclusions may be made about safety re-
garding steroid hormone consumption via commercial 
milk products because the effect of long-term ingestion 
at these levels is presently unknown (Zhou et al., 2007; 
Martini and Wood, 2009).
The average daily intake of E1 and E2 that would be 
consumed by the average US resident over the age of 2 
yr is also provided in Table 4. The average daily intake 
is based on the findings reported by the USDA for the 
years 2005 to 2006 (http://www.ars.usda.gov/SP2User-
Files/Place/12355000/pdf/DBrief/fluid_milk_0506.
pdf). In this study, individuals (both males and females) 
over the age of 2 were reported to consume slightly 
more than 3/4 cup of fluid milk per day. Converting 
this volume to 178 mL and multiplying by the mean 
levels of E1 and E2 found in the various milk products 
provides an estimate of the estrogen levels that would 
be consumed daily if an individual drunk exclusively 
one type of milk. The values range from 10.2 to 54.4 
ng from goat to organic whole milk, respectively. The 
daily intake of E1 and E2 consumed through goat milk 
is less than 42% of that ingested via regular whole milk, 
which contains the next lowest estrogen levels. To put 
these values into proper perspective, the data shows 
that the average American consumes less than 0.02% 
of the amount of estrogens through fluid milk than is 
ingested by an individual taking low-dose Premarin 
(i.e., 300 μg).
CONCLUSIONS
This study compared the unconjugated and total 
E1 and E2 concentrations in goat and cow milks (both 
regular and organic). The combined levels of these es-
trogen metabolites were significantly lower in goat milk; 
however, the differences between regular and organic 
cow milks were not as significant. Although the doses of 
either E1 or E2 were small compared with what would 
be ingested from taking Premarin, the cumulative ef-
fects of years of consumption are still unknown. Given 
the surprisingly low concentrations of conjugated and 
Table 4. Ratio of conjugated estrone (E1) and 17β-estradiol (E2) concentrations ingested from low- and regular-dose hormone replacement 
therapy (Premarin) to levels in milk products analyzed in this study1  
Item
Regular  
whole
Regular  
2%
Regular  
nonfat
Organic  
nonfat
Organic  
whole
Organic  
2%
Goat  
milk
Conjugated E1 + E2  
 (pg/mL)
137.8 ± 21.62 152.0 ± 26.26 154.7 ± 21.27 208.5 ± 41.17 305.8 ± 39.31 279.1 ± 27.61 57.38 ± 6.97
Low-dose Premarin  
  (E1 + E2)
2,178 1,973 1,939 1,439 981.0 1,075 5,228
Regular-dose Premarin  
  (E1 + E2)
4,537 4,111 4,039 2,997 2,043 2,239 10,892
Average daily intake  
 via milk2 (ng)
24.5 27.1 27.5 37.1 54.4 49.7 10.2
1The projected amount of E1 and E2 consumed daily by the average resident of the United States is also shown for each type of milk.
2The average daily intakes are based on statistics provided at http://www.ars.usda.gov/SP2UserFiles/Place/12355000/pdf/DBrief/fluid_
milk_0506.pdf for individuals greater than 2 yr of age and the mean values of E1 and E2 found in each milk product.
1708 FARLOW ET AL.
Journal of Dairy Science Vol. 95 No. 4, 2012
unconjugated E1 and E2 in regular goat milk, this milk 
would be a healthy dietary alternative for individuals 
concerned with steroid hormone consumption. We are 
currently trying to 1) quantitate the level of estrone 
sulfate in all of the milk forms used in this study to 
provide more support and confirmation for our initial 
findings and 2) refine our method to quantitate other 
EM derivatives of E1 and E2 in all milk forms analyzed 
in this study, including various catechol estrogens.
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